• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的生物等排体方法产生了具有改善的耐药性特征和良好的药代动力学性质的 HIV-1 NNRTIs。

Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties.

机构信息

Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012 Jinan, Shandong, P.R. China.

China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, 44 West Culture Road, 250012 Jinan, Shandong, PR China.

出版信息

J Med Chem. 2020 May 14;63(9):4837-4848. doi: 10.1021/acs.jmedchem.0c00117. Epub 2020 Apr 22.

DOI:10.1021/acs.jmedchem.0c00117
PMID:32293182
Abstract

The development of efficacious NNRTIs for AIDS therapy commonly encountered the rapid generation of drug-resistant mutations, which becomes a major impediment to effective anti-HIV treatment. Using a structure-based bioisosterism strategy, a series of piperidine-substituted thiophene[2,3-]pyrimidine derivatives were designed and synthesized. Compound yielded the greatest potency, exhibiting significantly better anti-HIV-1 activity than against all of the tested NNRTI-resistant HIV-1 strains. In addition, the phenotypic (cross)resistance of and other NRTIs to the different selected HIV-1 strains was evaluated. As expected, no phenotypic cross-resistance against the NRTIs (AZT and PMPA) was observed with the mutant strain. Furthermore, was identified with improved solubility, lower CYP liability, and hERG inhibition. Remarkably, exhibited optimal pharmacokinetic properties in rats ( = 37.06%) and safety in mice (LD > 2000 mg/kg), which highlights as a promising anti-HIV-1 drug candidate.

摘要

高效抗逆转录病毒疗法(Highly active antiretroviral therapy,HAART)是一种通过联合使用多种抗逆转录病毒药物来抑制 HIV 复制的治疗方法,HAART 可以显著降低 HIV 载量,提高 CD4+T 细胞计数,减少 HIV 相关并发症和死亡率。

然而,HAART 也存在一些局限性,如药物副作用、耐药性、药物相互作用、经济负担等。因此,需要不断开发新的抗 HIV 药物,以满足临床需求。

近年来,基于结构的药物设计(Structure-based drug design,SBDD)已经成为一种有效的药物发现方法,可以帮助我们更好地理解药物与靶点之间的相互作用,从而设计出更加高效和特异性的药物。

在抗 HIV 药物的研究中,SBDD 已经取得了一些重要的进展,例如,发现了一些高效的 HIV 蛋白酶抑制剂、HIV 整合酶抑制剂、HIV 逆转录酶抑制剂等。

此外,基于 SBDD 的药物再利用(Drug repurposing)也是一种有效的药物发现方法,可以利用已经上市的药物来治疗新的疾病。在抗 HIV 药物的研究中,已经发现了一些可以用于治疗 HIV 感染的药物,例如,抗疟药氯喹、抗结核药利福平、免疫调节剂干扰素等。

总之,基于结构的药物设计和药物再利用为抗 HIV 药物的研究提供了新的思路和方法,有助于我们开发出更加高效和特异性的抗 HIV 药物,为 HIV 感染的治疗提供更好的选择。

相似文献

1
Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties.基于结构的生物等排体方法产生了具有改善的耐药性特征和良好的药代动力学性质的 HIV-1 NNRTIs。
J Med Chem. 2020 May 14;63(9):4837-4848. doi: 10.1021/acs.jmedchem.0c00117. Epub 2020 Apr 22.
2
Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel.发现并表征氟取代的二芳基嘧啶衍生物作为新型 HIV-1 NNRTIs,具有高度改善的耐药谱和对 hERG 离子通道的低活性。
J Med Chem. 2020 Feb 13;63(3):1298-1312. doi: 10.1021/acs.jmedchem.9b01769. Epub 2020 Jan 24.
3
Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.噻吩并[3,2-d]嘧啶衍生物作为具有显著改善耐药性的HIV-1非核苷类逆转录酶抑制剂的设计、合成与评价
J Med Chem. 2016 Sep 8;59(17):7991-8007. doi: 10.1021/acs.jmedchem.6b00738. Epub 2016 Aug 26.
4
Development of Novel Dihydrofuro[3,4-]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C.开发新型二氢呋喃并[3,4-d]嘧啶衍生物作为 HIV-1 NNRTIs,以克服高度耐药突变株 F227L/V106A 和 K103N/Y181C。
J Med Chem. 2022 Feb 10;65(3):2458-2470. doi: 10.1021/acs.jmedchem.1c01885. Epub 2022 Jan 21.
5
Discovery of Novel Dihydrothiopyrano[4,3-]pyrimidine Derivatives as Potent HIV-1 NNRTIs with Significantly Reduced hERG Inhibitory Activity and Improved Resistance Profiles.发现新型二氢噻吩并[4,3-d]嘧啶衍生物作为强效 HIV-1 NNRTIs,具有显著降低 hERG 抑制活性和改善耐药性特征。
J Med Chem. 2021 Sep 23;64(18):13658-13675. doi: 10.1021/acs.jmedchem.1c01015. Epub 2021 Aug 25.
6
Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.基于结构的噻吩并[3,2-d]嘧啶衍生物优化:作为强效HIV-1非核苷类逆转录酶抑制剂,对耐药相关变体的活性增强
J Med Chem. 2017 May 25;60(10):4424-4443. doi: 10.1021/acs.jmedchem.7b00332. Epub 2017 May 15.
7
2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies.作为强效 HIV-1 NNRTIs 的 2,4,5-三取代嘧啶类化合物:合理设计、合成、活性评估及晶体结构研究。
J Med Chem. 2021 Apr 8;64(7):4239-4256. doi: 10.1021/acs.jmedchem.1c00268. Epub 2021 Mar 18.
8
Identification of Dihydrofuro[3,4- d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties.鉴定二氢呋喃并[3,4-d]嘧啶衍生物为新型 HIV-1 非核苷类逆转录酶抑制剂,具有良好的抗病毒活性和理想的理化性质。
J Med Chem. 2019 Feb 14;62(3):1484-1501. doi: 10.1021/acs.jmedchem.8b01656. Epub 2019 Jan 18.
9
Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-]pyrimidine non-nucleoside inhibitors.噻吩[3,2-d]嘧啶类非核苷 HIV-1 RT 抑制剂强效广谱抑制作用的结构基础。
Elife. 2018 Jul 25;7:e36340. doi: 10.7554/eLife.36340.
10
Identification of novel potent HIV-1 inhibitors by exploiting the tolerant regions of the NNRTIs binding pocket.利用 NNRTIs 结合口袋的耐受区域鉴定新型有效的 HIV-1 抑制剂。
Eur J Med Chem. 2021 Mar 15;214:113204. doi: 10.1016/j.ejmech.2021.113204. Epub 2021 Jan 24.

引用本文的文献

1
Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors.基于生物电子等排体原理设计具有口服活性、安全性高且广谱的联苯 - DAPY衍生物作为高效HIV-1非核苷类逆转录酶抑制剂
Acta Pharm Sin B. 2025 Aug;15(8):4115-4136. doi: 10.1016/j.apsb.2025.06.016. Epub 2025 Jun 24.
2
Development of Anti-HIV Therapeutics: From Conventional Drug Discovery to Cutting-Edge Technology.抗HIV治疗药物的研发:从传统药物发现到前沿技术
Pharmaceuticals (Basel). 2024 Jul 4;17(7):887. doi: 10.3390/ph17070887.
3
Design and optimization of piperidine-substituted thiophene[3,2-]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profiles.
具有改善的耐药性和药代动力学特征的哌啶取代噻吩并[3,2 - ]嘧啶基HIV - 1非核苷类逆转录酶抑制剂的设计与优化
Acta Pharm Sin B. 2024 Jul;14(7):3110-3124. doi: 10.1016/j.apsb.2024.03.021. Epub 2024 Mar 27.
4
Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility.基于结构设计新型杂环取代的ATDP类似物作为具有更高选择性和溶解性的非核苷逆转录酶抑制剂。
Acta Pharm Sin B. 2023 Dec;13(12):4906-4917. doi: 10.1016/j.apsb.2023.07.008. Epub 2023 Jul 15.
5
Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs).非核苷类逆转录酶抑制剂(NNRTIs)的设计和开发策略。
Viruses. 2023 Sep 25;15(10):1992. doi: 10.3390/v15101992.
6
Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability.逆转录酶的皮摩尔级抑制剂,具有显著提高的代谢稳定性。
Acta Pharm Sin B. 2023 Jul;13(7):3054-3066. doi: 10.1016/j.apsb.2023.03.022. Epub 2023 Mar 29.
7
Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles.新型磺酰胺取代吲哚芳基砜作为具有更好安全性的强效HIV-1抑制剂的发现。
Acta Pharm Sin B. 2023 Jun;13(6):2747-2764. doi: 10.1016/j.apsb.2023.01.003. Epub 2023 Jan 11.
8
Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.发现含哌嗪磺酰基的二芳基嘧啶衍生物作为有效的HIV-1非核苷类逆转录酶抑制剂。
Commun Chem. 2023 Apr 29;6(1):83. doi: 10.1038/s42004-023-00888-4.
9
Development of fluorine-substituted NH-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability.含氟取代的NH-联苯-二芳基嘧啶作为高效非核苷类逆转录酶抑制剂的研发:提高安全性和代谢稳定性
Acta Pharm Sin B. 2023 Mar;13(3):1192-1203. doi: 10.1016/j.apsb.2022.08.017. Epub 2022 Aug 27.
10
Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.鉴定含硼酸酯的二芳基嘧啶衍生物作为新型 HIV-1 非核苷逆转录酶抑制剂。
Molecules. 2022 Nov 3;27(21):7538. doi: 10.3390/molecules27217538.